雍禾医疗（02279）今日盘中大跌5.24%，引发市场关注。这家主要从事植发业务的公司近期股价表现持续疲软，自7月28日以来已累计下跌46.35%。
公司最新发布的2025年中期报告显示，营业收入同比下降4.29%至8.62亿元，虽然净利润实现扭亏为盈，达2791万元，但这主要依赖于压缩成本费用实现。雍禾医疗面临多重挑战，包括核心业务收入下滑、门店扩张停滞以及人才流失等问题。值得注意的是，公司植发业务虽然手术量增加14.46%，但客单价下降14.03%，导致植发营收下降1.63%。
为应对这些挑战，雍禾医疗采取了一系列成本控制措施，包括削减销售和营销支出、压缩管理费用、关闭低效门店以及缩减研发投入。然而，分析人士指出，这种依赖压缩费用的做法虽然短期内美化了财务报表，但可能会影响公司的长期竞争力和市场覆盖能力。投资者对公司未来增长前景的担忧，可能是导致股价下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.